Fig. 2
From: Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
A Heatmap demonstrating differences in lipids, at baseline, between individuals with (n = 21) or without myocardial infarction (MI) (n = 41). B Selected examples of lipids, i.e., ceramide [Cer(d18:1/24:1)], triacylglycerol [TG(56:3)] and phosphatidylethanolamine [PE(35:5)], showing significant differences at baseline between groups with or without MI, with adjusted p values marked to the boxplots